Related Experiment Video
Updated: May 15, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Radical prostatectomy in high-risk prostate cancer
1Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada.
Summary
Men with high-risk prostate cancer benefit most from curative treatment. Radical prostatectomy offers local control and staging advantages, remaining a vital option despite some guidelines favoring radiation therapy.
Area of Science:
- Oncology
- Urology
- Surgical Oncology
Background:
- Men with high-risk or locally-advanced prostate cancer require curative treatment to prevent premature death.
- Combined androgen deprivation therapy plus radiation is increasingly standard, partly due to perceived radical prostatectomy morbidity.
- Current evidence lacks definitive proof of superiority between treatment modalities.
Purpose of the Study:
- To evaluate the role and benefits of radical prostatectomy in treating high-risk prostate cancer.
- To compare radical prostatectomy with combined androgen deprivation therapy plus radiation.
- To inform treatment discussions for men with high-risk prostate cancer.
Main Methods:
- Review of existing studies and guidelines on prostate cancer treatment.
- Analysis of treatment outcomes, morbidity, and staging accuracy.
- Comparative assessment of radical prostatectomy versus radiation therapy.
Main Results:
- Radical prostatectomy provides excellent local control without increased morbidity.
- Surgery accurately stages disease and aids in timely identification of treatment failures.
- No definitive evidence shows radiation therapy is superior to radical prostatectomy for high-risk disease.
Conclusions:
- Radical prostatectomy remains a crucial treatment option for high-risk prostate cancer.
- Despite guideline recommendations, surgery's efficacy and advantages warrant its inclusion in treatment discussions.
- Further randomized trials are needed to definitively establish treatment superiority.
